Skip to main content
Fig. 4 | Journal of Biomedical Science

Fig. 4

From: Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine

Fig. 4

Legend. In vivo antitumor effects generated by treatment with E7 DNA vaccine plus α-GalCer, E7 DNA vaccine plus MPL, E7 DNA vaccine plus α-GalCer and MPL combination. C57BL/6 mice were inoculated with 2 × 105 TC-1 tumor cells subcutaneously. Mice were then treated with DNA vaccine plus different adjuvant combinations as described in Materials and Methods. Mice were monitored for tumor growth by measuring diameters with calipers twice a week. Line and scatter plot graphs depicting the tumor volume (in mm3) are presented. The data presented are a representation of three independent experiments

Back to article page